Person

George A. Scangos

Director, Agilent Technologies

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$2.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • BIIB
    Biogen
    DirectorChief Executive Officer
    2016 or earlier – last filing Jul 2016

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jul 21, 2016BIIBSale157$280.00$44K
Jun 3, 2016BIIBSale842$290.00$244K
Jun 1, 2016BIIBSale487$287.97$140K
May 31, 2016BIIBSale3,368$290.00$977K
May 25, 2016BIIBSale157$280.00$44K
May 2, 2016BIIBSale487$274.74$134K
Apr 6, 2016BIIBSale157$280.00$44K
Apr 1, 2016BIIBSale487$258.83$126K
Mar 1, 2016BIIBSale487$261.37$127K
Feb 17, 2016BIIBSale487$256.16$125K

SEC reporting-owner ID (CIK) 1202102 · all filings on EDGAR